Clinical collaboration Opportunity to expand partnerships with blood banks and plasma/tissue handling facilities, leveraging ZipThaw as a safer, maintenance-light dry thawing solution to improve cell viability in cryopreserved products.

Clinical validation Recent collaboration with Comprehensive Cell Solutions to compare ZipThaw against water-bath thawing highlights a path to propose joint studies or pilot programs with additional клиnical labs and transplant centers seeking validated performance advantages.

Regulatory readiness ISO 13485:2016, FDA and CE marking indicate a solid regulatory foundation; sales opportunities can target hospitals, blood banks, and wholesalers requiring compliant medical devices for thawing and processing of lifesaving products.

Strategic partnerships Existing manufacturing partnerships (Minnetronix Medical, Boyd Biomedical) suggest a model for scaling through co-manufacturing and distribution agreements; identify additional OEM or contract manufacturing allies to broaden geography and channel reach.

SMB focus Small team size (2-10 employees) and mid-range revenue signals a need for scalable, easy-to-deploy solutions, as well as targeted marketing to mid-sized hospital networks and regional blood banks that benefit from streamlined thawing workflows and minimal maintenance.